Influences of the Common FTO rs9939609 Variant on Inflammatory Markers Throughout a Broad Range of Body Mass Index

Background A recent study reported that the fatness associated A-allele of FTO rs9939609 increased plasma high sensitivity C-reactive protein (hs-CRP) levels independent of fatness. We aimed to investigate if this gene variant had fatness-independent effects on plasma hs-CRP and 10 additional circulating obesity-related adipokines throughout a broad range of body mass index (BMI) among Danish men. Methodology/Principal Findings In a population of 362,200 young men, examined for military service between 1943 and 1977, two groups were identified: 1) a random 1% sample and 2) all obese men (BMI = 31.0 kg/m2, all of whom were above the 99th percentile of this population). At an average age of 49 years (range: 39 through 65 years), 551 men, hereof 231 of the obese, were re-examined, including genotyping and measurement of the fasting circulating inflammatory markers hs-CRP, IL-1β, IL-6, IL-10, IL-18, mip1α, mip1β, sTNFα-R1, TGF-β, TNF-α and leptin. Men with known disease were excluded from the examination. All the inflammatory markers were log-transformed to approximate a normal distribution. Genotype-phenotype relationships were studied using linear regression analyses with the inflammatory markers as the response variable. Significant positive associations between hs-CRP, leptin and a broad range of BMI were observed, but the associations did not significantly differ across FTO rs9939609 genotype. There were no significant associations between the other inflammatory markers, FTO rs9939609 genotype or BMI, respectively. Conclusion No fatness-independent effects of the FTO rs9939609 A-allele on a series of inflammatory markers were observed in this cohort of healthy middle-aged men representing a broad range of fatness.

[1]  Per Kragh Andersen,et al.  Regression with Linear Predictors , 2010 .

[2]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[3]  M. Schulze,et al.  Association of the FTO rs9939609 Single Nucleotide Polymorphism With C‐reactive Protein Levels , 2009, Obesity.

[4]  T. Hansen,et al.  FTO Gene Associated Fatness in Relation to Body Fat Distribution and Metabolic Traits throughout a Broad Range of Fatness , 2008, PloS one.

[5]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[6]  C. Block,et al.  Mechanisms linking obesity with cardiovascular disease , 2006, Nature.

[7]  T. Pischon Use of Obesity Biomarkers in Cardiovascular Epidemiology , 2009, Disease markers.

[8]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[9]  E. Haynes,et al.  Biomarkers of obesity and subsequent cardiovascular events. , 2007, Epidemiologic reviews.

[10]  T. Sørensen,et al.  Post-war course of the prevalence of extreme overweight among Danish young men. , 1977, Journal of chronic diseases.

[11]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[12]  D. Hougaard,et al.  Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. , 2005, Clinical chemistry.

[13]  Beverley Balkau,et al.  Variation in FTO contributes to childhood obesity and severe adult obesity , 2007, Nature Genetics.

[14]  T. Hansen,et al.  Fatness-Associated FTO Gene Variant Increases Mortality Independent of Fatness – in Cohorts of Danish Men , 2009, PloS one.

[15]  T. Sørensen,et al.  Constant median body mass index of Danish young men, 1943-1977. , 1981, Human biology.

[16]  FTO Gene Variant Is Associated with Obesity: Longitudinal Analyses in Two Cohort Studies and Functional Test , 2008 .

[17]  T. Hansen,et al.  Genotype-Phenotype Associations in Obesity Dependent on Definition of the Obesity Phenotype , 2008, Obesity Facts.

[18]  A. Morris,et al.  The FTO Gene Is Associated With an Atherogenic Lipid Profile and Myocardial Infarction in Patients With Type 2 Diabetes: A Genetics of Diabetes Audit and Research Study in Tayside Scotland (Go-DARTS) Study , 2009, Circulation: Cardiovascular Genetics.

[19]  Inês Barroso,et al.  The genetics of obesity: FTO leads the way , 2010, Trends in genetics : TIG.

[20]  J. Seidell,et al.  Epidemiology of obesity. , 2002, Seminars in vascular medicine.

[21]  K. Sworczak,et al.  Role of adipokines in complications related to obesity: a review. , 2009, Advances in medical sciences.

[22]  T. Sørensen,et al.  Mortality in extremely overweight young men. , 1977, Journal of chronic diseases.

[23]  B. Heitmann,et al.  Prevalence of obesity in Denmark , 2007, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[24]  D. Hougaard,et al.  Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples. , 2008, Journal of immunological methods.

[25]  O. Pedersen,et al.  Long‐term influences of body‐weight changes, independent of the attained weight, on risk of impaired glucose tolerance and Type 2 diabetes , 2005, Diabetic medicine : a journal of the British Diabetic Association.